Gastric Cancer Explained: Causes, Symptoms, Risk Factors, and Modern Treatment

What Is Gastric Cancer?

Gastric cancer, commonly referred to as stomach cancer, is a malignant disease that begins in the lining of the stomach. The stomach plays a central role in digestion by breaking down food through mechanical activity and gastric acid secretion. When abnormal cells begin to grow uncontrollably in the stomach lining, they can form tumors that progressively invade surrounding tissues.

Although gastric cancer can arise in any part of the stomach, tumor location varies across populations. In many regions worldwide, cancers commonly develop in the central portion of the stomach, known as the gastric body. In Western countries, including the United States and parts of Europe, tumors increasingly appear near the gastroesophageal junction, where the esophagus connects to the stomach.

Tumor location influences how the disease behaves, how it is staged, and which treatment strategies are recommended. When detected early and confined to the stomach wall, gastric cancer can often be treated successfully. Unfortunately, many cases are diagnosed at more advanced stages, when the cancer has already invaded deeper layers or spread beyond the stomach.

Why Early Gastric Cancer Often Goes Unnoticed

One of the challenges in diagnosing gastric cancer is that the disease frequently develops without clear symptoms during its early stages. Early lesions may grow slowly within the stomach lining and produce only mild digestive discomfort that resembles common gastrointestinal conditions.

Because these symptoms are vague, many people delay seeking medical evaluation. As the tumor grows or spreads, symptoms become more noticeable and may include persistent digestive disturbances or systemic signs of illness.

Common early symptoms may include:

• Persistent discomfort or pain in the upper abdomen

• Indigestion or heartburn that does not improve

• Feeling full quickly after eating small amounts of food

• Bloating after meals

• Nausea or occasional vomiting

• Loss of appetite

As the disease progresses, more concerning symptoms can appear:

• Unintentional weight loss

• Fatigue and weakness

• Difficulty swallowing

• Vomiting blood or passing black, tarry stools caused by gastrointestinal bleeding

In advanced cases, cancer may spread to nearby lymph nodes or distant organs. Liver involvement can lead to jaundice, while spread within the abdominal cavity may cause fluid accumulation known as ascites.

Because early symptoms are often subtle, persistent digestive complaints should be evaluated by a healthcare professional, especially in individuals with known risk factors.

How Gastric Cancer Develops

Gastric cancer typically develops through a gradual biological process involving chronic inflammation and progressive cellular damage within the stomach lining. Repeated injury to gastric epithelial cells can lead to genetic mutations that disrupt normal cell growth and repair mechanisms.

These mutations affect genes that regulate:

• Cell proliferation

• DNA repair processes

• Programmed cell death (apoptosis)

As damaged cells accumulate mutations, they may begin dividing uncontrollably. Over time, these abnormal cells can form malignant tumors that invade deeper layers of the stomach wall.

This process is often described as a multistep progression:

1. Chronic inflammation of the gastric mucosa

2. Cellular changes within the lining

3. Formation of precancerous lesions

4. Development of invasive carcinoma

Several environmental and biological factors may accelerate this process, including long-standing inflammation, dietary exposures, and persistent infection of the stomach lining.

However, exposure to risk factors does not guarantee cancer development. Gastric cancer arises from a complex interaction between environmental influences, genetic predisposition, and the body's immune response.

Major Histological Types of Gastric Cancer

Gastric cancer is classified according to the type of cells from which the tumor originates. Understanding the tumor type helps physicians determine prognosis and choose appropriate treatment strategies.

Adenocarcinoma

Adenocarcinoma is the most common form of gastric cancer and accounts for the vast majority of cases. These tumors originate from mucus-producing glandular cells that line the stomach. Adenocarcinomas can vary in aggressiveness depending on their cellular structure and pattern of growth.

Gastrointestinal Stromal Tumors (GIST)

GISTs are relatively rare tumors that develop from specialized cells in the stomach wall known as interstitial cells of Cajal, which regulate digestive tract motility. These tumors behave differently from adenocarcinomas and may respond to targeted therapies.

Neuroendocrine Tumors

These tumors arise from hormone-producing cells within the stomach lining. Some neuroendocrine tumors grow slowly, while others can be more aggressive depending on their biological characteristics.

Gastric Lymphoma

Gastric lymphoma develops from immune cells located in lymphoid tissue within the stomach wall. Certain forms of lymphoma are associated with chronic immune stimulation within the stomach lining.

Risk Factors That Increase Gastric Cancer Risk

Multiple lifestyle, environmental, and genetic factors have been linked to an increased risk of developing gastric cancer.

Important risk factors include:

• Diet high in salted, smoked, or heavily preserved foods

• Low intake of fruits and vegetables rich in antioxidants

• Long-standing inflammation of the stomach lining

• Tobacco use

• Chronic acid reflux

• Gastric polyps or other precancerous conditions

• Family history of gastric cancer

Genetic syndromes can also increase susceptibility. These include:

• Hereditary diffuse gastric cancer

• Lynch syndrome

• Peutz–Jeghers syndrome

• Familial adenomatous polyposis

• Juvenile polyposis syndrome

Individuals with these conditions may require specialized screening programs to detect early disease.

Diagnostic Evaluation and Staging

Accurate diagnosis requires a combination of clinical evaluation, imaging studies, and tissue analysis.

The primary diagnostic tool is upper gastrointestinal endoscopy, a procedure in which a flexible camera is inserted through the mouth to examine the stomach lining. During endoscopy, physicians can identify suspicious lesions and obtain biopsies for microscopic analysis.

Additional imaging techniques help determine how far the cancer has spread. These may include:

• Computed tomography (CT) scans

• Endoscopic ultrasound

• Positron emission tomography (PET) imaging

Staging the tumor is critical for determining treatment options and predicting prognosis. Early-stage cancers limited to the stomach wall are generally more treatable than those that have spread to distant organs.

Modern Treatment Approaches

Treatment strategies depend on multiple factors, including tumor stage, location, histological type, and the patient’s overall health.

Surgical Treatment

Surgery remains the primary treatment for localized gastric cancer. Procedures may involve removing part of the stomach (partial gastrectomy) or the entire stomach (total gastrectomy), along with nearby lymph nodes.

Systemic Therapies

For more advanced disease, treatment may include additional therapies such as chemotherapy or targeted treatments designed to destroy cancer cells throughout the body.

These treatments may be used:

• Before surgery to shrink tumors

• After surgery to reduce recurrence risk

• As primary therapy when surgery is not possible

Multimodal Treatment

In many cases, the most effective approach combines several treatment methods. Coordinated care involving surgeons, oncologists, and supportive specialists can improve survival outcomes and quality of life.

Prevention and Risk Reduction

Although gastric cancer cannot always be prevented, certain lifestyle and dietary choices may help lower the risk of developing the disease.

Protective measures include:

• Consuming a diet rich in fruits and vegetables

• Reducing intake of salted, smoked, and heavily preserved foods

• Avoiding tobacco use

• Managing chronic digestive conditions

• Seeking medical evaluation for persistent gastrointestinal symptoms

For individuals with strong family history or inherited risk syndromes, medical monitoring and early screening may help detect disease at earlier, more treatable stages.

Early diagnosis remains one of the most important factors in improving survival and treatment success.

Scientific References

Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. The Lancet. 2020.

Ajani JA et al. Gastric cancer clinical practice guidelines. National Comprehensive Cancer Network (NCCN).

Correa P. A human model of gastric carcinogenesis. Cancer Research. 1988.

Crew KD, Neugut AI. Epidemiology of gastric cancer. World Journal of Gastroenterology. 2006.

Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer overview. The Lancet. 2016.